Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

KNSA GB00BRXB0C07

💰
Capitalization
Small-cap

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

🔗
Website
https://www.kiniksa.com
Annual Performance 1
2021 2022 2023 2024 2025
-31% 21% 21% 7% 2%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
125
🙍
Insiders
8
Person Price Shares Total Published Completed
Tessari Eben
COO 		38.33
USD 		42,000
Sold 		1,609,860
USD 		29/09/2025 29/09/2025
Tessari Eben
COO 		37.00
USD 		356
Sold 		13,172
USD 		15/09/2025 15/09/2025
Tessari Eben
COO 		36.45
USD 		16,044
Sold 		584,804
USD 		15/09/2025 15/09/2025
Tessari Eben
COO 		35.66
USD 		13,389
Sold 		477,452
USD 		04/09/2025 05/09/2025
Tessari Eben
COO 		35.52
USD 		85,271
Sold 		3,028,826
USD 		04/09/2025 04/09/2025
Moat Ross
SR EXX 		35.31
USD 		3,523
Sold 		124,397
USD 		04/09/2025 04/09/2025
Megna Michael R
CCO 		34.84
USD 		11,000
Sold 		383,240
USD 		01/09/2025 03/09/2025
Tessari Eben
COO 		35.50
USD 		15,091
Sold 		535,731
USD 		01/09/2025 03/09/2025
Megna Michael R
CCO 		34.84
USD 		11,000
Sold 		383,240
USD 		01/09/2025 03/09/2025
Tessari Eben
COO 		34.44
USD 		100
Sold 		3,444
USD 		18/08/2025 18/08/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-25% -24% 3% 39% 4% 0% 4%
Last 52W Low 52W High All-Time Low All-Time High β
38.31 18.17 38.83 5.24 38.83
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Tessari Eben 34 21,488,160.95 632,004.73 01/03/2024 29/09/2025
Patel Sanj K 24 12,729,354.42 530,389.77 04/03/2024 28/05/2025
Ragosa Mark 17 7,428,397.00 436,964.53 03/01/2024 04/08/2025
Moat Ross 12 6,717,788.83 559,815.74 03/09/2024 04/09/2025
Malley Thomas 3 5,859,815.05 1,953,271.68 12/08/2025 14/08/2025
Megna Michael R 14 4,347,017.08 310,501.22 19/12/2023 03/09/2025
Paolini John F. 15 4,257,859.24 283,857.28 07/12/2023 06/08/2025
Quart Barry D 6 1,666,002.72 277,667.12 09/06/2025 11/06/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.